Aemetis (AMTX) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
12 Mar, 2026Executive summary
Q4 2025 revenue plus tax credits rose to $53.7 million from $47 million year-over-year, with gross profit improving to $7.7 million from a $2 million loss.
Net loss for Q4 improved to $5.3 million from $16.2 million, and full-year net loss improved to $77 million from $87.5 million in 2024.
Dairy RNG production rose 61% year-over-year in Q4 2025, with 12 operating digesters producing 405,000 MMBtu annually and achieving positive segment net income and EBITDA.
Mechanical vapor recompression (MVR) upgrade at the Keyes ethanol plant is expected to increase annual cash flow by $32 million upon completion in 2026.
India biodiesel facility generated $29.7 million in revenue, with expansion into biogas and sustainable aviation fuel underway and IPO planned for 2026.
Financial highlights
Q4 2025 operating loss improved to $2.5 million from $13.5 million year-over-year.
Full-year 2025 revenue plus tax credits was $208 million, down from $268 million in 2024.
Ethanol and RNG operations generated $10.3 million in production tax credits in Q4.
Cash at year-end 2025 was $4.9 million, up from $898 thousand at year-end 2024.
Adjusted EBITDA for 2025 was $(19.6) million, compared to $(18.8) million in 2024.
Outlook and guidance
RNG production expected to grow in 2026 as more dairy digesters come online, with equipment contracted for 15 digesters.
MVR system at Keyes ethanol plant to be completed in 2026, reducing natural gas use by 80% and boosting cash flow.
Focus on scaling production, monetizing environmental credits, completing India IPO, and long-term debt refinancing.
Cash flow for 2026 expected to significantly exceed 2025, driven by 45Z credits and rising LCFS prices.
California legislative approval of year-round E15 in October 2025 could expand the ethanol market by 50%.
Latest events from Aemetis
- Q2 revenue up 48% to $66.6M, but net loss widened and liquidity concerns persist.AMTX
Q2 20242 Feb 2026 - Board approves executive bonuses, $80M share buyback, and charter amendments for share structure.AMTX
Proxy Filing28 Jan 2026 - Q3 2024 revenue up 19% to $81.4M, but net loss and liquidity risks remain.AMTX
Q3 202414 Jan 2026 - Stockholders to vote on key changes to capital structure and meeting procedures, with Board support.AMTX
Proxy Filing31 Dec 2025 - Revenue up 43% to $268M, but net loss widened; policy and tax credits to drive future growth.AMTX
Q4 202426 Dec 2025 - Votes sought to amend capital structure and empower Board for future growth and flexibility.AMTX
Proxy Filing19 Dec 2025 - Up to $234 million in securities may be offered amid ongoing losses and risk disclosures.AMTX
Registration Filing16 Dec 2025 - Shelf registration allows up to $210M in flexible securities offerings; audit notes internal control weaknesses.AMTX
Registration Filing16 Dec 2025 - Shareholders will vote on director elections, auditor ratification, and executive pay, with board support.AMTX
Proxy Filing1 Dec 2025